Rigel Pharmaceuticals, Inc. Revenue 2016–2025
Rigel Pharmaceuticals, Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Rigel Pharmaceuticals, Inc. revenue for the quarter ending March 31, 2026 was 58.8 M, a 10.28% increase year-over-year.
- Rigel Pharmaceuticals, Inc. revenue for the twelve months ending March 31, 2026 was 283.3 M, a 89.10% increase year-over-year.
- Rigel Pharmaceuticals, Inc. annual revenue for 2025 was 294.3 M, a 64.15% increase from 2024.
- Rigel Pharmaceuticals, Inc. annual revenue for 2024 was 179.3 M, a 53.38% increase from 2023.
- Rigel Pharmaceuticals, Inc. annual revenue for 2023 was 116.9 M, a 2.79% decrease from 2022.
- Rigel Pharmaceuticals, Inc. annual revenue for 2022 was 120.2 M.
Rigel Pharmaceuticals, Inc. (RIGL) — Frequently Asked Questions
Rigel Pharmaceuticals, Inc. (RIGL) is a publicly traded US company. It has a market capitalization of $582M. In fiscal 2025 it reported revenue of $294M and net income of $367M. Explore RIGL's stock price, financial statements, earnings history, margins and key ratios below.
What is Rigel Pharmaceuticals, Inc.'s market cap?
Rigel Pharmaceuticals, Inc. (RIGL) has a market capitalization of $582M.
What is the RIGL stock price?
RIGL trades at $30.91 (+0.62% on the day).
How much revenue does Rigel Pharmaceuticals, Inc. make?
Rigel Pharmaceuticals, Inc. reported revenue of $294M in fiscal 2025.
Is RIGL profitable?
In fiscal 2025, Rigel Pharmaceuticals, Inc. reported net income of $367M.